Loading...
XIDX
MERK
Market cap83mUSD
Nov 12, Last price  
3,090.00IDR
Name

Merck Tbk PT

Chart & Performance

D1W1MN
XIDX:MERK chart
P/E
9.02
P/S
1.34
EPS
342.55
Div Yield, %
10.36%
Shrs. gr., 5y
—
Rev. gr., 5y
6.84%
Revenues
1.04t
+7.83%
386,345,803,000487,601,198,000547,237,994,000637,134,080,000751,403,033,000795,688,800,000918,532,462,000929,876,824,0001,193,952,302,000863,207,535,000983,446,471,0001,034,806,890,0001,156,648,155,000611,958,076,000744,634,530,000655,847,125,0001,064,394,815,0001,124,599,738,000961,433,965,0001,036,747,709,000
Net income
153.46b
-13.90%
57,700,045,00086,537,702,00089,484,528,00098,620,070,000146,700,178,000118,794,278,000231,158,647,000107,808,155,000175,444,757,000181,472,234,000142,545,462,000153,842,847,000144,677,294,0001,163,324,165,00078,256,797,00071,902,263,000131,660,834,000179,837,759,000178,240,003,000153,463,416,000
CFO
55.71b
-72.67%
000000088,404,562,000133,099,062,000232,826,497,000160,700,345,00043,799,001,000129,919,801,000168,964,859,000-210,843,887,00071,983,458,000169,814,591,000188,483,757,000203,874,886,00055,711,527,000
Dividend
Jun 07, 2024320 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
URL
https://www.merckgroup.com/id-id
IPO date
Jul 23, 1981
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT